Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Finegold

Showing results (131-140 of 488) with videos related to

Pageof 49
Sort By:
The Journal of Antimicrobial Chemotherapy|June 1, 1985
In-vitro activity of Sch 34343 against anaerobic bacteriaH Wexler, W T Carter, S M Finegold
Clinical Therapeutics|November 1, 1989
Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strainsH M Wexler, D Reeves, S M Finegold
Antimicrobial Agents and Chemotherapy|January 1, 1992
In vitro activities of three of the newer quinolones against anaerobic bacteriaH M Wexler, E Molitoris, S M Finegold
Infection|June 23, 1999
A primer on anaerobic bacteria and anaerobic infections for the uninitiatedI Olsen, C O Solberg, S M Finegold
Antimicrobial Agents and Chemotherapy|October 29, 2008
Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel floraS M Finegold, D Molitoris, M-L Väisänen
Antimicrobial Agents and Chemotherapy|June 1, 1991
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteriaH M Wexler, E Molitoris, S M Finegold
Reviews of Infectious Diseases|January 1, 1991
Pericardial actinomycosis: case report and reviewT D Fife, S M Finegold, T Grennan
Applied Microbiology|January 1, 1973
Comparison of methods for isolation of anaerobic bacteria from clinical specimensJ E Rosenblatt, A Fallon, S M Finegold
Clinical Pediatrics|August 1, 1980
Neonatal pneumonia caused by members of the Bacteroides fragilis groupI Brook, W J Martin, S M Finegold
Reviews of Infectious Diseases|January 1, 1979
In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteriaV L Sutter, B Kirby, S M Finegold
Pageof 49

Showing results (131-140 of 488) with videos related to

Sort By:
Pageof 49
The Journal of Antimicrobial Chemotherapy|June 1, 1985
In-vitro activity of Sch 34343 against anaerobic bacteriaH Wexler, W T Carter, S M Finegold
Clinical Therapeutics|November 1, 1989
Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strainsH M Wexler, D Reeves, S M Finegold
Antimicrobial Agents and Chemotherapy|January 1, 1992
In vitro activities of three of the newer quinolones against anaerobic bacteriaH M Wexler, E Molitoris, S M Finegold
Infection|June 23, 1999
A primer on anaerobic bacteria and anaerobic infections for the uninitiatedI Olsen, C O Solberg, S M Finegold
Antimicrobial Agents and Chemotherapy|October 29, 2008
Study of the in vitro activities of rifaximin and comparator agents against 536 anaerobic intestinal bacteria from the perspective of potential utility in pathology involving bowel floraS M Finegold, D Molitoris, M-L Väisänen
Antimicrobial Agents and Chemotherapy|June 1, 1991
Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteriaH M Wexler, E Molitoris, S M Finegold
Reviews of Infectious Diseases|January 1, 1991
Pericardial actinomycosis: case report and reviewT D Fife, S M Finegold, T Grennan
Applied Microbiology|January 1, 1973
Comparison of methods for isolation of anaerobic bacteria from clinical specimensJ E Rosenblatt, A Fallon, S M Finegold
Clinical Pediatrics|August 1, 1980
Neonatal pneumonia caused by members of the Bacteroides fragilis groupI Brook, W J Martin, S M Finegold
Reviews of Infectious Diseases|January 1, 1979
In vitro activity of cefoxitin and parenterally administered cephalosporins against anaerobic bacteriaV L Sutter, B Kirby, S M Finegold
Pageof 49